Sastasundar Ventures Limited (IN:SASTASUNDR)
:SASTASUNDR
SASTASUNDR Stock Chart & Stats
₹311.85
-₹1.25(-0.39%)
At close: 4:00 PM EST
₹311.85
-₹1.25(-0.39%)
Day’s Range― - ―
52-Week Range₹241.50 - ₹375.00
Previous CloseN/A
Volume8.84K
Average Volume (3M)4.89K
Market Cap
₹8.56B
Enterprise Value₹8.39B
Total Cash (Recent Filing)₹240.06M
Total Debt (Recent Filing)₹51.49M
Price to Earnings (P/E)207.7
Beta0.87
Next Earnings
May 28, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.35
Shares Outstanding31,810,500
10 Day Avg. Volume1,551
30 Day Avg. Volume4,895
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)1.20
Price to Sales (P/S)0.74
P/FCF Ratio-29.09
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-17.6
Revenue Forecast (FY)₹33.40B
Bulls Say, Bears Say
Bulls Say
Balance-sheet StrengthA substantial equity base and low leverage provide a durable solvency cushion, lowering refinancing risk during operating weakness. This balance-sheet strength allows management to fund strategic fixes or investments without immediate external debt, improving resilience over a 2–6 month horizon.
Consumer Healthcare PlatformAn integrated digital and distribution-led healthcare model targets recurring demand for medicines and services. Structural demand for healthcare and an omnichannel fulfilment capability support sustainable revenue channels and cross-sell opportunities, aiding medium-term revenue stability if execution holds.
Historical Topline GrowthDocumented revenue growth in the prior year signals product-market fit and addressable demand. That historical momentum suggests the company can re-expand revenue if operational inefficiencies are fixed, providing a credible path to recovery over several quarters rather than being purely cyclical.
Bears Say
Declining Revenue And LossesMaterial top-line decline coupled with a swing to sizeable net losses erodes operating scale and retained earnings. Persistent revenue contraction impairs margin recovery and makes sustainable profitability dependent on substantive strategy or market-share improvements, raising medium-term execution risk.
Weak Cash GenerationFailure to convert revenue into operating cash and sharply lower free cash flow increases reliance on external funding and limits capital allocation. Sustained negative cash generation constrains investment in growth or margin fixes and elevates liquidity risk over the coming quarters.
Negative Operating MarginsNegative EBIT/EBITDA margins signal structural cost or mix problems that impair scalability. Even with topline recovery, poor margin economics reduce free cash flow potential and return on capital, requiring deeper operational restructuring to restore durable profitability.
Sastasundar Ventures Limited News
SASTASUNDR FAQ
What was Sastasundar Ventures Limited’s price range in the past 12 months?
Sastasundar Ventures Limited lowest stock price was ₹241.50 and its highest was ₹375.00 in the past 12 months.
What is Sastasundar Ventures Limited’s market cap?
Sastasundar Ventures Limited’s market cap is ₹8.56B.
When is Sastasundar Ventures Limited’s upcoming earnings report date?
Sastasundar Ventures Limited’s upcoming earnings report date is May 28, 2026 which is in 50 days.
How were Sastasundar Ventures Limited’s earnings last quarter?
Sastasundar Ventures Limited released its earnings results on Feb 06, 2026. The company reported ₹0.355 earnings per share for the quarter, beating the consensus estimate of N/A by ₹0.355.
Is Sastasundar Ventures Limited overvalued?
According to Wall Street analysts Sastasundar Ventures Limited’s price is currently Overvalued.
Does Sastasundar Ventures Limited pay dividends?
Sastasundar Ventures Limited pays a Annually dividend of ₹1 which represents an annual dividend yield of N/A. See more information on Sastasundar Ventures Limited dividends here
What is Sastasundar Ventures Limited’s EPS estimate?
Sastasundar Ventures Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sastasundar Ventures Limited have?
Sastasundar Ventures Limited has 31,810,500 shares outstanding.
What happened to Sastasundar Ventures Limited’s price movement after its last earnings report?
Sastasundar Ventures Limited reported an EPS of ₹0.355 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.017%.
Which hedge fund is a major shareholder of Sastasundar Ventures Limited?
Currently, no hedge funds are holding shares in IN:SASTASUNDR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Sastasundar Ventures Limited
Sastasundar Ventures Limited operates a digital network of healthcare in India. It finances loans, and invests in shares and securities, as well as provides financial consultancy, professional fees, wealth management, financial planning, distribution, and related services. The company also operates sastasundar.com and retailershakti.com portal for pathology and healthcare products marketing activities, as well as provides diagnostic services, such as pathological/radiological investigations. In addition, it distributes medicines and wellness products; and provides customized heath supplements and diet counselling, as well as health information services. The company was formerly known as Microsec Financial Services Limited and changed its name to Sastasundar Ventures Limited in November 2016. Sastasundar Ventures Limited was incorporated in 1989 and is based in Kolkata, India.